Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension.
about
Molecular pathogenesis of pulmonary arterial hypertensionHereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of diseaseMolecular mechanisms of pulmonary arterial remodelingPulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Mutational and clinical analysis of the ENG gene in patients with pulmonary arterial hypertensionPulmonary arterial hypertension: the clinical syndrome.Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.Three novel BMPR2 mutations associated with advanced pulmonary arterial hypertensionPulmonary arterial hypertension: Specialists' knowledge, practices, and attitudes of genetic counseling and genetic testing in the USAFuture breakthroughs in the genetics of pulmonary arterial hypertension.Heritable forms of pulmonary arterial hypertension.Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.PDGF signaling in pulmonary arterial hypertension.Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report.Identification of a new intronic BMPR2-mutation and early diagnosis of heritable pulmonary arterial hypertension in a large family with mean clinical follow-up of 12 years.Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.Mutation in BMPR2 Promoter: A 'Second Hit' for Manifestation of Pulmonary Arterial Hypertension?High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary HypertensionAccurate genetic diagnosis of Finnish pulmonary arterial hypertension patients using oligonucleotide-selective sequencing.Decreased Endoglin expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia rat model.A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension.Identification of Biomarkers for Schistosoma-Associated Pulmonary Arterial Hypertension Based on RNA-Seq Data of Mouse Whole Lung Tissues.Pulmonary arterial hypertension: an imaging review comparing MR pulmonary angiography and perfusion with multidetector CT angiography.Pathogenic mechanisms of pulmonary arterial hypertension.Molecular pathogenesis of pulmonary arterial hypertensionGenetics and mediators in pulmonary arterial hypertensionPulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.Integrating molecular genetics and systems approaches to pulmonary vascular diseases.Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).Genetics and genomics of pulmonary arterial hypertension.Genes and the preeclampsia syndrome.Genetics of pulmonary arterial hypertension.Signal transduction in the development of pulmonary arterial hypertensionUpdate in pulmonary hypertension 2008.Genomics of pulmonary arterial hypertension: implications for therapy.Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.Relevant issues in the pathology and pathobiology of pulmonary hypertension.The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.
P2860
Q24634317-D2611E16-9CAB-4A1A-B223-D716DD315E4CQ24645017-546D89DE-8F9C-4129-9AC0-7FF662297165Q26991806-D70CCD36-0606-4EB5-9FCE-41516AD14A16Q27687091-E0203DB3-223C-41C2-B067-E3BE653F3B0FQ28601711-22D2F797-0F27-4C3F-8FCB-17E3679DF55CQ30583630-7B5770ED-27A2-4FD7-951A-BE6858AB58D4Q33265315-3EA04656-D6C2-4A03-A257-7EC821D69591Q33580827-F76E2B09-687A-46A4-933D-2E2970ED14ACQ33788468-9B1F05F9-74C8-4405-9570-E192479B638DQ33806126-C469FC31-E5BD-4793-BA48-7A7E62C3B275Q33915567-E409F7DC-5224-4930-878C-FAAB4F13454AQ33968765-979975EA-FA32-4B83-8900-77245C88B827Q34048526-186045DF-196B-43D2-A64D-222C589D92B2Q34535086-A488B96D-273F-45F9-AD2B-D203697695B9Q35118881-3FECC31C-7C13-4D47-AD76-F812305D0950Q35140747-B18C4919-193F-42FD-8819-FB568FF68F10Q35185797-3E806914-09D6-4C90-9082-D3FBA2BDB88BQ35689320-BBCB8563-36F9-4698-B996-8CC37A900FF8Q35907239-FDDB621D-A5C5-49A4-B5E3-43A7B7A34179Q35907757-79DA36B8-324D-4067-93AB-24F56C7067BFQ36185229-2E75240A-F2C3-4673-8C98-72C8C737BB09Q36340262-F4B3A295-6AC8-4BB1-80FB-1456BD46EF8AQ36341659-50A958E9-C5F9-4E89-94E6-D9429C8BC80EQ36407000-FD80957A-DCBB-44B7-B6CD-2C16FEF449F6Q36447388-CAB0E94F-F2A7-4D53-A8CF-89E25558FF51Q36736065-7576DE9F-BBE2-4C00-82E8-8B8E3AFDFACDQ36752306-01EF96E5-D504-4D6B-A569-A34D759A42A8Q36769101-EB78A122-7C73-4D03-B8A4-3DAD36BDCC0EQ36810797-2A9CFE38-33DA-476A-A5BC-DD1EBA3EDC93Q36886900-DC539F92-9277-457A-8155-88CF510A1A23Q37051037-344046D1-680D-429B-AE0B-33E4850C79DFQ37053831-5055EAE0-FBB3-450C-B6CA-398E91BC395EQ37080526-85C1DD05-9CE3-457B-874B-7C2FABD061B1Q37133785-B3C76B66-4111-483C-9412-87D1626C2BF3Q37436774-3312E899-2990-49F0-A440-734C1DCD1495Q37452405-A423E678-8C4A-4A48-8B31-B4744C17F165Q37671277-F8917134-B956-440B-A1E7-BA3F2889F60AQ37673917-1B7D5AD1-BED0-49C8-9199-402C28379EFDQ37851851-1079CE51-DD93-4A16-8AB2-CB727AC1D29CQ37882523-BB49CABA-B7D3-4A9B-98E6-FD3762FEB0EB
P2860
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Endoglin germline mutation in ...... lmonary arterial hypertension.
@ast
Endoglin germline mutation in ...... lmonary arterial hypertension.
@en
type
label
Endoglin germline mutation in ...... lmonary arterial hypertension.
@ast
Endoglin germline mutation in ...... lmonary arterial hypertension.
@en
prefLabel
Endoglin germline mutation in ...... lmonary arterial hypertension.
@ast
Endoglin germline mutation in ...... lmonary arterial hypertension.
@en
P2093
P356
P1433
P1476
Endoglin germline mutation in ...... lmonary arterial hypertension.
@en
P2093
E Weitzenblum
F Soubrier
G Simonneau
P304
P356
10.1136/THX.2003.11890
P407
P577
2004-05-01T00:00:00Z